GM-CSF (Granulocyte-macrophage colony-stimulating factor)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GM-CSF (Granulocyte-macrophage colony-stimulating factor), covering 2012-06-28 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. [Phase 4]